These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virus. Ferenczy MW Curr Pharm Des; 2007; 13(19):1975-88. PubMed ID: 17627531 [TBL] [Abstract][Full Text] [Related]
3. Prospects and perspectives for development of a vaccine against herpes simplex virus infections. McAllister SC; Schleiss MR Expert Rev Vaccines; 2014 Nov; 13(11):1349-60. PubMed ID: 25077372 [TBL] [Abstract][Full Text] [Related]
4. Prospects for control of herpes simplex virus disease through immunization. Stanberry LR; Cunningham AL; Mindel A; Scott LL; Spruance SL; Aoki FY; Lacey CJ Clin Infect Dis; 2000 Mar; 30(3):549-66. PubMed ID: 10722443 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of herpes simplex virus infection and pathogenesis suggest a strategy for vaccine development. Xu X; Zhang Y; Li Q Rev Med Virol; 2019 Jul; 29(4):e2054. PubMed ID: 31197909 [TBL] [Abstract][Full Text] [Related]
6. [Herpes simplex virus vaccine studies: from past to present]. Us D Mikrobiyol Bul; 2006 Oct; 40(4):413-33. PubMed ID: 17205702 [TBL] [Abstract][Full Text] [Related]
8. Recent progress in herpes simplex virus immunobiology and vaccine research. Koelle DM; Corey L Clin Microbiol Rev; 2003 Jan; 16(1):96-113. PubMed ID: 12525427 [TBL] [Abstract][Full Text] [Related]
9. Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines. Stanberry LR Herpes; 2004 Aug; 11 Suppl 3():161A-169A. PubMed ID: 15319086 [TBL] [Abstract][Full Text] [Related]
10. The potential impact of a prophylactic herpes simplex vaccine. Rupp R; Bernstein DI Expert Opin Emerg Drugs; 2008 Mar; 13(1):41-52. PubMed ID: 18321147 [TBL] [Abstract][Full Text] [Related]
11. Status of vaccine research and development of vaccines for herpes simplex virus. Johnston C; Gottlieb SL; Wald A Vaccine; 2016 Jun; 34(26):2948-2952. PubMed ID: 26973067 [TBL] [Abstract][Full Text] [Related]
13. The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccine. Kuo T; Wang C; Badakhshan T; Chilukuri S; BenMohamed L Vaccine; 2014 Nov; 32(50):6733-45. PubMed ID: 25446827 [TBL] [Abstract][Full Text] [Related]
14. Toward the Eradication of Herpes Simplex Virus: Vaccination and Beyond. Chang JY; Balch C; Oh HS Viruses; 2024 Sep; 16(9):. PubMed ID: 39339952 [TBL] [Abstract][Full Text] [Related]
16. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response. Bettahi I; Zhang X; Afifi RE; BenMohamed L Viral Immunol; 2006; 19(2):220-36. PubMed ID: 16817765 [TBL] [Abstract][Full Text] [Related]
17. A review of HSV pathogenesis, vaccine development, and advanced applications. Bai L; Xu J; Zeng L; Zhang L; Zhou F Mol Biomed; 2024 Aug; 5(1):35. PubMed ID: 39207577 [TBL] [Abstract][Full Text] [Related]
18. Current thinking on genital herpes. Hofstetter AM; Rosenthal SL; Stanberry LR Curr Opin Infect Dis; 2014 Feb; 27(1):75-83. PubMed ID: 24335720 [TBL] [Abstract][Full Text] [Related]
19. [Status quo of the researches on HSV vaccines]. Gao J; Lu JC; Huang YF Zhonghua Nan Ke Xue; 2009 Jan; 15(1):60-4. PubMed ID: 19288753 [TBL] [Abstract][Full Text] [Related]
20. Herpes simplex: insights on pathogenesis and possible vaccines. Koelle DM; Corey L Annu Rev Med; 2008; 59():381-95. PubMed ID: 18186706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]